We’re rated Excellent
4.7 out of 5 based on 100 reviews

Hot Summer Weekend Reading June 25

The clinical progress of mRNA vaccines and immunotherapies

The clinical progress of mRNA vaccines and immunotherapies | Nature Biotechnology

Regenerative and restorative medicine for eye disease

Regenerative and restorative medicine for eye disease | Nature Medicine

Leveraging technology to personalize cognitive enhancement methods in aging

Leveraging technology to personalize cognitive enhancement methods in aging | Nature Aging

Carbon Biosciences emerges with a new viral vector to shake up the cystic fibrosis gene therapy field

Carbon Biosciences emerges with a new viral vector to shake up the cystic fibrosis gene therapy field – Endpoints News (endpts.com)

Single MRI-based brain scan could diagnose Alzheimer’s disease, says study

Single MRI-based brain scan could diagnose Alzheimer’s disease, says study - (pharmaphorum.com)

Center for Breakthrough Medicines plans for an even larger dive into cell therapy manufacturing

Center for Breakthrough Medicines plans for an even larger dive into cell therapy manufacturing – Endpoints News (endpts.com)

In pursuit of accessible sickle cell cure, Novartis inks $1.5B deal to tap Precision's ARCUS gene editing tech

In pursuit of accessible sickle cell cure, Novartis inks $1.5B deal to tap Precision’s ARCUS gene editing tech – Endpoints News (endpts.com)

Galapagos finally takes M&A plunge, spending $251M for 2 biotechs in CAR-T push

Galapagos takes M&A plunge, spending $251M for CAR-T push (fiercebiotech.com)

Nature Outlook - Smell

Our sense of smell has a reputation for being underdeveloped — but this is ill-founded. The events of the past two years, in which millions of people lost their sense of smell to COVID-19, have put the spotlight on research emerging from the world of olfaction.

Smell (nature.com)

The joint battle to tackle epidermolysis bullosa through gene therapy

The joint battle to tackle epidermolysis bullosa through gene therapy: Trends in Molecular Medicine (cell.com)

BioNTech's solid tumor CAR-T hits prime time with EU regulatory tag

BioNTech's solid tumor CAR-T hits PRIME time with EU tag (fiercebiotech.com)

Sanofi, GSK say dual-acting vaccine prevents COVID-19 from omicron in large trial

Sanofi, GSK say dual-acting vaccine prevents COVID-19 from omicron in large trial | BioPharma Dive

Little-known OrbiMed-backed biotech closes $160M round to start gene therapy trial

Scoop: Little-known OrbiMed-backed biotech closes $160M round to start gene therapy trial – Endpoints News (endpts.com)